|
Abrami, L., Kunz, B., Iacovache, I., van der Goot, F.G., 2008. Palmitoylation and ubiquitination regulate exit of the Wnt signaling protein LRP6 from the endoplasmic reticulum. Proc. Natl. Acad. Sci. U. S. A. 105, 5384-5389.
|
|
Abrami, L., Leppla, S.H., van der Goot, F.G., 2006. Receptor palmitoylation and ubiquitination regulate anthrax toxin endocytosis. J. Cell Biol. 172, 309-320.
|
|
Afrin, S., El Sabeh, M., Islam, M.S., Miyashita-Ishiwata, M., Malik, M., Catherino, W.H., Akimzhanov, A.M., Boehning, D., Yang, Q., Al-Hendy, A., et al., 2021. Simvastatin modulates estrogen signaling in uterine leiomyoma via regulating receptor palmitoylation, trafficking and degradation. Pharmacol. Res. 172, 105856.
|
|
Ali, A., Levantini, E., Teo, J.T., Goggi, J., Clohessy, J.G., Wu, C.S., Chen, L., Yang, H., Krishnan, I., Kocher, O., et al., 2018. Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non-small cell lung cancer. EMBO Mol. Med. 10, e8313.
|
|
Anam, Z., Kumari, G., Mukherjee, S., Rex, D.A.B., Biswas, S., Maurya, P., Ravikumar, S., Gupta, N., Kushawaha, A.K., Sah, R.K., et al., 2022. Complementary crosstalk between palmitoylation and phosphorylation events in MTIP regulates its role during Plasmodium falciparum invasion. Front. Cell. Infect. Microbiol. 12, 924424.
|
|
Anania, V.G., Coscoy, L., 2011. Palmitoylation of MIR2 is required for its function. J. Virol. 85, 2288-2295.
|
|
Bai, X., Guo, Y.R., Zhang, W.C., Shi, Z.H., Dai, D.Q., 2026. Targeting the ZDHHC9-mediated STAT1 palmitoylation-phosphorylation conversion inhibits gastric cancer progression. J. Gastroenterol. 61, 369-385.
|
|
Barylko, B., Taylor, C.A., Wang, J., Earnest, S., Stippec, S., Binns, D.D., Brautigam, C.A., Jameson, D.M., DeMartino, G.N., Cobb, M.H., et al., 2024. Mimicking protein kinase C phosphorylation inhibits Arc/Arg3.1 palmitoylation and its interaction with nucleic acids. Int. J. Mol. Sci. 25, 780.
|
|
Blaustein, M., Piegari, E., Martinez Calejman, C., Vila, A., Amante, A., Manese, M.V., Zeida, A., Abrami, L., Veggetti, M., Guertin, D.A., et al., 2021. Akt Is S-palmitoylated: a new layer of regulation for Akt. Front. Cell. Dev. Biol. 9, 626404.
|
|
Brigidi, G.S., Santyr, B., Shimell, J., Jovellar, B., Bamji, S.X., 2015. Activity-regulated trafficking of the palmitoyl-acyl transferase DHHC5. Nat. Commun. 6, 8200.
|
|
Bu, N., Du, Q., Xiao, T., Jiang, Z.H., Lin, J.H., Chen, W.Y., Fan, B.W., Wang, J.Y., Xia, H.B., Cheng, C., et al., 2025. Mechanism of S-palmitoylation in polystyrene nanoplastics-induced macrophage cuproptosis contributing to emphysema through alveolar epithelial cell pyroptosis. ACS Nano 19, 18708-18728.
|
|
Chang, Y.L., Zhu, J.L., Li, X.P., Deng, Y., Lai, B.R., Ma, Y.D., Tong, J., Liu, H.C., Li, J.J., Yang, C.Y., et al., 2024. Palmitoylation regulates myelination by modulating the ZDHHC3-Cadm4 axis in the central nervous system. Signal Transduction Targeted Ther. 9, 254.
|
|
Charych, E.I., Jiang, L.X., Lo, F., Sullivan, K., Brandon, N.J., 2010. Interplay of palmitoylation and phosphorylation in the trafficking and localization of phosphodiesterase 10A: implications for the treatment of schizophrenia. J. Neurosci. 30, 9027-9037.
|
|
Chen, Q.T., Zhang, Z.Y., Huang, Q.L., Chen, H.Z., Hong, W.B., Lin, T.W., Zhao, W.X., Wang, X.M., Ju, C.y., Wu, L.z., et al., 2022. HK1 from hepatic stellate cell-derived extracellular vesicles promotes progression of hepatocellular carcinoma. Nat. Metab. 4, 1306-1321.
|
|
Chen, S.S., Shen, H.Y., Zhang, H.Y., Wang, Q., Ding, Y., Pu, X.X., Yang, C., Pang, R.X., Yang, Z., 2026. ZDHHC4-mediated ZEB-2 S-palmitoylation promotes melanoma epithelial-mesenchymal transition via deubiquitinating and stabilizing ZEB-2. Cell. Mol. Life Sci. 83, 87.
|
|
Chen, S.Y., Zhu, B., Yin, C.Q., Liu, W., Han, C.P., Chen, B.E., Liu, T.Z., Li, X., Chen, X., Li, C.Y., et al., 2017. Palmitoylation-dependent activation of MC1R prevents melanomagenesis. Nature 549, 399-403.
|
|
Chen, T., Zhang, H.L., Lv, S.T., Xu, Y., Ren, W., Wei, Y.F., Zhang, T.Y., Ge, Y.R., Lv, Y., Li, R.Y., et al., 2025. Amelioration of intervertebral disc degeneration using engineered extracellular vesicle-delivered ZDHHC5 via inhibiting PANoptosis. J. Tissue Eng. 16, 20417314251351011.
|
|
Chen, X.R., Ma, H.H., Wang, Z., Zhang, S.R., Yang, H.R., Fang, Z.Y., 2017. EZH2 palmitoylation mediated by ZDHHC5 in p53-mutant glioma drives malignant development and progression. Cancer Res. 77, 4998-5010.
|
|
Chen, X.Y., Ke, Z.H., Wei, S.H., Chen, J.J., Zhu, K., Xu, J.Q., Zhao, Y., Cen, M.Y., Jin, Y., Pan, Z.L., et al., 2026. ASCT2 palmitoylation regulated by JNK1-ZDHHC14 axis orchestrates glutamine metabolism and NSCLC progression. Cell Discov. 12, 13.
|
|
Cherukuri, A., Carter, R.H., Brooks, S., Bornmann, W., Finn, R., Dowd, C.S., Pierce, S.K., 2004. B cell signaling is regulated by induced palmitoylation of CD81. J. Biol. Chem. 279, 31973-31982.
|
|
Copits, B.A., Swanson, G.T., 2013. Kainate receptor post-translational modifications differentially regulate association with 4.1N to control activity-dependent receptor endocytosis. J. Biol. Chem. 288, 8952-8965.
|
|
Ettelaie, C., Featherby, S., Rondon, A.M.R., Greenman, J., Versteeg, H.H., Maraveyas, A., 2021. De-palmitoylation of tissue factor regulates its activity, phosphorylation and cellular functions. Cancers (Basel) 13, 3837.
|
|
Fairbank, M., Huang, K., El-Husseini, A., Nabi, I.R., 2012. RING finger palmitoylation of the endoplasmic reticulum Gp78 E3 ubiquitin ligase. FEBS Lett. 586, 2488-2493.
|
|
Fan, Y.Z., Gao, Y., Nie, L., Hou, T., Dan, W.C., Wang, Z.X., Liu, T.J., Wei, Y., Wang, Y.Z., Liu, B., et al., 2023. Targeting LYPLAL1-mediated cGAS depalmitoylation enhances the response to anti-tumor immunotherapy. Mol. Cell 83, 3520-3532.
|
|
Fu, H., Han, X., Guo, W.Q., Zhao, X.N., Yu, C.X., Zhao, W., Feng, S.S., Wang, J., Zhang, Z.S., Lei, K.J., et al., 2024. Cystathionine-γ-lyase contributes to tamoxifen resistance, and the compound I194496 alleviates this effect by inhibiting the PPARγ/ACSL1/STAT3 signalling pathway in oestrogen receptor-positive breast cancer. Sci. Rep. 14, 22988.
|
|
Gauthier-Kemper, A., Igaev, M., Sundermann, F., Janning, D., Bruhmann, J., Moschner, K., Reyher, H.J., Junge, W., Glebov, K., Walter, J., et al., 2014. Interplay between phosphorylation and palmitoylation mediates plasma membrane targeting and sorting of GAP43. Mol. Biol. Cell 25, 3284-3299.
|
|
Gu, M.R., Jiang, H.L., Tan, M.Z., Yu, L., Xu, N., Li, Y., Wu, H., Hou, Q., Dai, C.S., 2023. Palmitoyltransferase DHHC9 and acyl protein thioesterase APT1 modulate renal fibrosis through regulating β-catenin palmitoylation. Nat. Commun. 14, 6682.
|
|
Guo, F.J., Luo, Y., Jiang, X.Y., Lu, X.Q., Roberti, D., Lossos, C., Kunkalla, K., Magistri, M., Rui, L.X., Verdun, R., et al., 2020. Recent BCR stimulation induces a negative autoregulatory loop via FBXO10 mediated degradation of HGAL. Leukemia 34, 553-566.
|
|
Guo, H., Lin, Z., Zhang, D., Qin, Q., Li, Z., Yin, Y., Chen, J., Guo, W., 2025. ZDHHC9-mediated CD38 palmitoylation stabilizes CD38 expression and promotes pancreatic cancer growth. Commun. Biol. 8, 477.
|
|
Harris, M., El Hindy, M., Usmari-Moraes, M., Hudd, F., Shafei, M., Dong, M., Hezwani, M., Clark, P., House, M., Forshaw, T., et al., 2020. BCAT-induced autophagy regulates Aβ load through an interdependence of redox state and PKC phosphorylation-implications in Alzheimer's disease. Free Radic. Biol. Med. 152, 755-766.
|
|
Hawtin, S.R., Tobin, A.B., Patel, S., Wheatley, M., 2001. Palmitoylation of the vasopressin V1a receptor reveals different conformational requirements for signaling, agonist-induced receptor phosphorylation, and sequestration. J. Biol. Chem. 276, 38139-38146.
|
|
Itoh, M., Yamashita, M., Kaneko, M., Okuno, H., Abe, M., Yamazaki, M., Natsume, R., Yamada, D., Kaizuka, T., Suwa, R., et al., 2018. Deficiency of AMPAR-palmitoylation aggravates seizure susceptibility. J. Neurosci. 38, 10220-10235.
|
|
Jeffries, O., Tian, L., McClafferty, H., Shipston, M.J., 2012. An electrostatic switch controls palmitoylation of the large conductance voltage- and calcium-activated potassium (BK) channel. J. Biol. Chem. 287, 1468-1477.
|
|
Jeong, D.W., Park, J.W., Kim, K.S., Kim, J., Huh, J., Seo, J., Kim, Y.L., Cho, J.-Y., Lee, K.-W., Fukuda, J., et al., 2023. Palmitoylation-driven PHF2 ubiquitination remodels lipid metabolism through the SREBP1c axis in hepatocellular carcinoma. Nat. Commun. 14, 6370.
|
|
Jiang, L., Bin, Y., Huang, Y.Y., Wu, L.H., Qiu, X.Y., Du, Y.C., Mi, J.L., Liu, K., Deng, Y.Y., Ning, J.C., et al., 2026. Palmitoylation modification of SPI1 promotes nasopharyngeal carcinoma radioresistance through inhibiting c-CBL-mediated ubiquitination and degradation. Drug Resist. Update. 86, 101374.
|
|
Komaniecki, G., Camarena, M.D.C., Gelsleichter, E., Mendoza, R., Subler, M., Windle, J.J., Dozmorov, M.G., Lai, Z., Sarkar, D., Lin, H.N., 2022. Astrocyte elevated gene-1 Cys75 S-palmitoylation by ZDHHC6 regulates its biological activity. Biochemistry 62, 543-553.
|
|
Lai, B.R., Xu, C., Lai, S.Y., Zhou, M., Kong, H.S., Kong, E.Y., Yahaya, B.H., 2026. From EGFR PTM network to TKI resistance: spatial subtypes and targeting in lung cancer. Cancer Drug Resist. 9, 7.
|
|
Li, M., Yu, X.X., Liu, Y.J., Ouyang, S.Q., Wu, L., Chen, X.H., Yu, H.Q., Chen, H.M., Lian, S.M., Li, Z.W., et al., 2025. KRAS/ABHD17C/ALOX15B axis promotes pancreatic cancer progression via ferroptosis evasion. Adv. Sci. 12, e04470.
|
|
Li, T.Z., Bai, C.Y., Wu, B., Zhang, C.Y., Siriguleng, Wang, W.T., Shi, T.W., Zhou, J., 2023. The Elk-3 target Abhd10 ameliorates hepatotoxic injury and fibrosis in alcoholic liver disease. Commun. Biol. 6, 682.
|
|
Li, W., Wang, Q.X., Qi, X.Y., Lu, H.M., Chen, Y.H., Shi, J.L., Wang, F., Wang, Z.Y., Lu, Y., Lu, Z.M., et al., 2020. An oncogenic viral interferon regulatory factor upregulates CUB domain-containing protein 1 to promote angiogenesis by hijacking transcription factor lymphoid enhancer-binding factor 1 and metastasis suppressor CD82. Cell Death Differ. 27, 3289-3306.
|
|
Li, Z., Huang, Z., Liao, X., Li, H., 2025. Columbianadin targets TRIM7 to maintain P2X7 palmitoylation, inhibiting cuproptosis in synovial M2 macrophages. Phytomedicine 146, 157091.
|
|
Liang, D., Jiang, L., Bhat, S.A., Missiroli, S., Perrone, M., Lauriola, A., Adhikari, R., Gudur, A., Vasi, Z., Ahearn, I., et al., 2023. Palmitoylation and PDE6δ regulate membrane-compartment-specific substrate ubiquitylation and degradation. Cell Rep. 42, 111999.
|
|
Lievens, P.M.-J., Kuznetsova, T., Kochlamazashvili, G., Cesca, F., Gorinski, N., Galil, D.A., Cherkas, V., Ronkina, N., Lafera, J., Gaestel, M., et al., 2023. ZDHHC3 tyrosine phosphorylation regulates neural cell adhesion molecule palmitoylation. Mol. Cell. Biol. 36, 2208-2225.
|
|
Lin, D.T., Makino, Y., Sharma, K., Hayashi, T., Neve, R., Takamiya, K., Huganir, R.L., 2009. Regulation of AMPA receptor extrasynaptic insertion by 4.1N, phosphorylation and palmitoylation. Nat. Neurosci. 12, 879-887.
|
|
Liu, J., Shen, Y.Y., Liu, J., Xu, D.D., Chang, C.Y., Wang, J.M., Zhou, J., Haffty, B.G., Zhang, L.J., Bargonetti, J., et al., 2025. Lipogenic enzyme FASN promotes mutant p53 accumulation and gain-of-function through palmitoylation. Nat. Commun. 16, 1762.
|
|
Liu, S.F., Zhang, N., Ji, X., Yang, S.Y., Zhao, Z., Li, P., 2025. Helicobacter pylori CagA promotes gastric cancer immune escape by upregulating SQLE. Cell Death Dis. 16, 17.
|
|
Liu, X.F., Yu, J.T., Chen, Y.J., Liu, H.R., Liu, N., Peng, Q.S., 2026. Brucella abortus infection exploits ZDHHC3-mediated STAT3 palmitoylation to regulate host responses and promote persistence. Vet. Res. 57, 2.
|
|
Liu, Z., Wang, H., Han, Y.M., Chen, Y., Wang, Y.Y., Zhang, S.Y., Mo, Y.Q., Wang, C.J., Xiao, M.M., Xu, B., 2025. ZDHHC20-mediated S-palmitoylation of KAP1/TRIM28 promotes DNA damage repair. Oncogene 44, 4533-4548.
|
|
Lu, B., Sun, Y.Y., Chen, B.Y., Yang, B., He, Q.J., Li, J., Cao, J., 2024. zDHHC20-driven S-palmitoylation of CD80 is required for its costimulatory function. Acta Pharmacol. Sin. 45, 1214-1223.
|
|
Lu, X.Q., Sicard, R., Jiang, X.Y., Stockus, J.N., McNamara, G., Abdulreda, M., Moy, V.T., Landgraf, R., Lossos, I.S., 2015. HGAL localization to cell membrane regulates B-cell receptor signaling. Blood 125, 649-657.
|
|
Ma, X.C., Xia, Q.Q., Liu, K., Wu, Z.C., Li, C.X., Xiao, C.G., Dong, N.H., Hameed, M., Anwar, M.N., Li, Z.J., et al., 2023. Palmitoylation at residue C221 of Japanese encephalitis virus NS2A protein contributes to viral replication efficiency and virulence. J. Virol. 97, e0038223.
|
|
Mo, Y.Q., Han, Y.M., Chen, Y., Fu, C.L., Li, Q., Liu, Z., Xiao, M.M., Xu, B., 2024. ZDHHC20 mediated S-palmitoylation of fatty acid synthase (FASN) promotes hepatocarcinogenesis. Mol. Cancer 23, 274.
|
|
Modica, G., Tejeda-Valencia, L., Sauvageau, E., Yasa, S., Maes, J., Skorobogata, O., Lefrancois, S., 2025. Phosphorylation on serine 72 modulates Rab7A palmitoylation and retromer recruitment. J. Cell Sci. 138, jcs262177.
|
|
Moritz, A.E., Rastedt, D.E., Stanislowski, D.J., Shetty, M., Smith, M.A., Vaughan, R.A., Foster, J.D., 2015. Reciprocal phosphorylation and palmitoylation control dopamine transporter kinetics. J. Biol. Chem. 290, 29095-29105.
|
|
Nakao, F., Kobayashi, S., Mogami, K., Mizukami, Y., Shirao, S., Miwa, S., Todoroki-Ikeda, N., Ito, M., Matsuzaki, M., 2002. Involvement of Src family protein tyrosine kinases in Ca(2+) sensitization of coronary artery contraction mediated by a sphingosylphosphorylcholine-Rho-kinase pathway. Circ. Res. 91, 953-960.
|
|
Nie, L., Fei, C.J., Fan, Y.Z., Dang, F.B., Zhao, Z.Y., Zhu, T.F., Wu, X.Y., Dai, T., Balasubramanian, A., Pan, J., et al., 2024. Consecutive palmitoylation and phosphorylation orchestrates NLRP3 membrane trafficking and inflammasome activation. Mol. Cell 84, 3336-3353.e3337.
|
|
Niki, Y., Adachi, N., Fukata, M., Fukata, Y., Oku, S., Makino-Okamura, C., Takeuchi, S., Wakamatsu, K., Ito, S., Declercq, L., et al., 2023. S-palmitoylation of tyrosinase at cysteine500 regulates melanogenesis. J. Invest. Dermatol. 143, 317-327.e316.
|
|
Peng, F., Lu, J.X., Su, K.Y., Liu, X.Y., Luo, H.D., He, B., Wang, C.X., Zhang, X.Y., An, F., Lv, D.K., et al., 2024. Oncogenic fatty acid oxidation senses circadian disruption in sleep-deficiency-enhanced tumorigenesis. Cell Metab. 36, 1598-1618.e1511.
|
|
Qian, Z.W., Jiang, Y., Cai, Y., Gao, E.L., Wang, C.Z., Dong, J.F., Wang, F.X., Liu, L., Wu, D.P., Zhang, F., et al., 2025. FASN inhibits ferroptosis in breast cancer via USP5 palmitoylation-dependent regulation of GPX4 deubiquitination. J. Exp. Clin. Cancer Res. 44, 289.
|
|
Santonico, E., Belleudi, F., Panni, S., Torrisi, M.R., Cesareni, G., Castagnoli, L., 2010. Multiple modification and protein interaction signals drive the Ring finger protein 11 (RNF11) E3 ligase to the endosomal compartment. Oncogene 29, 5604-5618.
|
|
Sauvat, A., Ciccosanti, F., Colavita, F., Di Rienzo, M., Castilletti, C., Capobianchi, M.R., Kepp, O., Zitvogel, L., Fimia, G.M., Piacentini, M., et al., 2020. On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2. Cell Death Dis. 11, 656.
|
|
Shao, S., Li, W., Hong, Y.L., Zeng, R.J., Zhu, L., Yi, L., Li, Y., Wang, Y.H., Huang, H.J., Jiang, X.W., et al., 2025. ZDHHC2-dependent palmitoylation dictates ferroptosis and castration sensitivity in prostate cancer via controlling ACSL4 degradation and lipid peroxidation. Adv. Sci. 23, e14077.
|
|
Sharma, C., Rabinovitz, I., Hemler, M.E., 2012. Palmitoylation by DHHC3 is critical for the function, expression, and stability of integrin alpha6beta4. Cell. Mol. Life Sci. 69, 2233-2244.
|
|
Shi, Y., Du, L.Y., Lv, D.D., Li, H., Shang, J., Lu, J.J., Zhou, L.Y., Bai, L., Tang, H., 2019. Exosomal interferon-induced transmembrane protein 2 transmitted to dendritic cells inhibits interferon alpha pathway activation and blocks anti-hepatitis B virus efficacy of exogenous interferon alpha. Hepatology 69, 2396-2413.
|
|
Shipston, M., 2011. Ion channel regulation by protein palmitoylation. J. Biol. Chem. 286, 8709-8716.
|
|
Sun, H., Cui, Z., Li, C., Gao, Z., Xu, J., Bian, Y., Gu, T., Zhang, J., Li, T., Zhou, Q., et al., 2024. USP5 promotes ripretinib resistance in gastrointestinal stromal tumors by MDH2 deubiquition. Advanced Science 11, e2401171.
|
|
Takahashi, K., Niki, T., Ogawa, E., Fumika, K., Nishioka, Y., Sawa, M., Arai, H., Mukai, K., Taguchi, T., 2021. A cell-free assay implicates a role of sphingomyelin and cholesterol in STING phosphorylation. Sci. Rep. 11, 11996.
|
|
Tan, X.H., Li, K.F., Yuan, Y.M., Xia, M.C., Zhao, F.Z., Ying, H.G., Zhou, Z., Gao, P.C., Xie, G.Q., Li, X.S., et al., 2026. Palmitoylation-mediated ubiquitination of SRPK1 regulates ferroptosis in high-fat-induced erectile dysfunction. Adv. Sci. 13, e13796.
|
|
Tian, L.J., Jeffries, O., McClafferty, H., Molyvdas, A., Rowe, I.C.M., Saleem, F., Chen, L., Greaves, J., Chamberlain, L.H., Knaus, H.-G., et al., 2008. Palmitoylation gates phosphorylation-dependent regulation of BK potassium channels. Proc. Natl. Acad. Sci. U. S. A. 105, 21006-21011.
|
|
Wang, K.F., He, W., Gong, Z., Gao, J., Gao, T.Y., Pan, N., Wu, D.Z., Yang, Y.J., Li, Z., Zhao, X., et al., 2025. ZDHHC11-mediated palmitoylation alleviates chondrocyte senescence and serves as a therapeutic target for osteoarthritis. Nat. Aging 5, 2228-2246.
|
|
Wang, L.P., Wang, J.W., Ma, X.Q., Ju, G.M., Shi, C.F., Wang, W., Wu, J., 2023. USP35 promotes HCC development by stabilizing ABHD17C and activating the PI3K/AKT signaling pathway. Cell Death Discov. 9, 421.
|
|
Wang, L.Q., Li, M.Q., Lian, G.Y., Yang, S., Cai, J., Cai, Z., Wu, Y.X., Cui, J., 2024. Palmitoylation acts as a checkpoint for MAVS aggregation to promote antiviral innate immune responses. J. Clin. Invest. 134, e177924.
|
|
Wang, Y., Chen, Z.X., Li, R., Wei, D., Wang, S., Luo, H., Tu, Y.M., Liu, C., Xu, H.B., Xu, J.C., et al., 2025. S-palmitoylation of c-MET by CK2α-mediated zDHHC15 phosphorylation drives glioblastoma stem cell tumorigenicity. Neuro-Oncology 27, 1972-1986.
|
|
Wang, Y., Ma, H.Y., Zhang, B.W., Li, S.N., Lu, B.J., Qi, Y.C., Liu, T.T., Wang, H., Kang, X.H., Liang, Y.M., et al., 2025. Protein palmitoylation in hepatic diseases: Functional insights and therapeutic strategies. J. Adv. Res. 76, 307-326.
|
|
Wang, Y., Shen, N., Yang, Y., Xia, Y., Zhang, W.H., Lu, Y., Wang, Z.C., Yang, Z., Wang, Z.J., 2024. ZDHHC5-mediated S-palmitoylation of FAK promotes its membrane localization and epithelial-mesenchymal transition in glioma. Cell Commun. Signal. 22, 46.
|
|
Wang, Z.J., Wang, Y., Shen, N., Liu, Y., Xu, X.Y., Zhu, R.Q., Jiang, H., Wu, X.T., Wei, Y.F., Tang, J.Y., 2024. AMPKα1-mediated ZDHHC8 phosphorylation promotes the palmitoylation of SLC7A11 to facilitate ferroptosis resistance in glioblastoma. Cancer Lett. 584, 216619.
|
|
Wu, M.Y., Hu, L.Q., He, L.L., Yuan, L., Yang, L.L., Zhao, B., Zhang, L., He, X.J., 2024. The tumor suppressor NF2 modulates TEAD4 stability and activity in Hippo signaling via direct interaction. J. Biol. Chem. 300, 107212.
|
|
Wu, M.Z., Zhou, X.J., Zhou, X.Y., Wang, G.X., Zeng, Y.Q., Li, J., Prochownik, E.V., Wang, F.B., Li, Y.J., 2024. ZDHHC3-mediated SCAP S-acylation promotes cholesterol biosynthesis and tumor immune escape in hepatocellular carcinoma. Cell Rep. 43, 114962.
|
|
Xia, T.J., Cui, Y., Shi, H., Ma, Z.L., Gu, X.P., 2014. The effect of NR2B subunit palmitoylation at the spinal level after chronic dorsal root ganglia compression in rats. Anesth. Analg. 119, 1208-1214.
|
|
Xiong, W.F., Sun, K.Y., Zhu, Y., Zhang, X.Q., Zhou, Y.H., Zou, X.P., 2021. Metformin alleviates inflammation through suppressing FASN-dependent palmitoylation of Akt. Cell Death Dis. 12, 934.
|
|
Xu, J.N., Huo, L., Liu, J.T., Xu, W., Yu, T., 2026. Ketogenic diet can inhibit epileptic seizures by inhibiting RGMa methylation to promote GluA1 palmitoylation in the epileptic rat model. Nutr. Metab. (Lond.) 23, 30.
|
|
Xu, M.H., Zheng, Y.M., Chen, J.B., Gao, C., Zhu, M., Ma, A.Y., Liang, B.G., Xu, W.X., Fan, J., Zhou, H.B., et al., 2025. CLDN4 palmitoylation promotes hepatic-to-biliary lineage transition and lenvatinib resistance in hepatocellular carcinoma. Cell Rep. Med. 6, 102208.
|
|
Xu, M.X., Tan, J., Zhu, L.C., Ge, C.X., Zhang, Y., Gao, F.F., Dai, X.L., Kuang, Q., Chai, J., Zou, B.K., et al., 2023. Palmitoyltransferase ZDHHC3 aggravates nonalcoholic steatohepatitis by targeting S-palmitoylated IRHOM2. Adv. Sci. 10, e2302130.
|
|
Yamanashi, Y., Kanai, M., 2026. Catalytic strategies for post-translational modifications regulating protein higher-order structure and properties. Chem. Soc. Rev. 55, 4409-4425.
|
|
Yan, P.P., Liu, H.C., Zhou, T., Sun, P., Wang, Y.L., Wang, X.B., Zhang, L., Wang, T., Dong, J., Zhu, J., et al., 2022. Crosstalk of Synapsin1 palmitoylation and phosphorylation controls the dynamicity of synaptic vesicles in neurons. Cell Death Dis. 13, 786.
|
|
Yang, J.-W., Larson, G., Konrad, L., Shetty, M., Holy, M., Jantsch, K., Kastein, M., Heo, S., Erdem, F.A., Lubec, G., et al., 2019. Dephosphorylation of human dopamine transporter at threonine 48 by protein phosphatase PP1/2A up-regulates transport velocity. J. Biol. Chem. 294, 3419-3431.
|
|
Yao, H., Lan, J., Li, C.S., Shi, H.B., Brosseau, J.P., Wang, H.B., Lu, H.J., Fang, C.Y., Zhang, Y., Liang, L.X., et al., 2019. Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours. Nat Biomed Eng. 3, 306-317.
|
|
Yin, H., Gui, Y., Du, G.W., Frohman, M.A., Zheng, X.L., 2010. Dependence of phospholipase D1 multi-monoubiquitination on its enzymatic activity and palmitoylation. J. Biol. Chem. 285, 13580-13588.
|
|
Zhang, G.H., Jiang, P.S., Tang, W., Wang, Y.Y., Qiu, F.Q., An, J., Zheng, Y.P., Wu, D.D., Zhou, J.Y., Neculai, D., et al., 2023. CPT1A induction following epigenetic perturbation promotes MAVS palmitoylation and activation to potentiate antitumor immunity. Mol. Cell 83, 4370-4385.e4379.
|
|
Zhang, M.M., Yu, T., Liu, Y.N., Lu, X., Chen, W.Z., Zhou, L.X., Xu, Y.J., Yang, M., Miller, A.D., Lin, H.N., 2025. SMAD2 S-palmitoylation promotes its linker region phosphorylation and TH 17 cell differentiation in a mouse model of multiple sclerosis. Sci. Signal. 18, eadr2008.
|
|
Zhang, M.M., Zhou, L.X., Xu, Y.J., Yang, M., Xu, Y.L., Komaniecki, G.P., Kosciuk, T., Chen, X., Lu, X., Zou, X., et al., 2020. A STAT3 palmitoylation cycle promotes TH17 differentiation and colitis. Nature 586, 434-439.
|
|
Zhang, N., Liu, J.P., Guo, R., Yan, L.J., Yang, Y.X., Shi, C., Zhang, M.M., Shan, B., Li, W.J., Gu, J.Y., et al., 2024. Palmitoylation licenses RIPK1 kinase activity and cytotoxicity in the TNF pathway. Mol. Cell 84, 4419-4435.
|
|
Zhang, W.G., Trible, R.P., Samelson, L.E., 1998. LAT palmitoylation: its essential role in membrane microdomain targeting and tyrosine phosphorylation during T cell activation. Immunity 9, 239-246.
|
|
Zhang, Z.Y., Ren, C.Y., Xiao, R., Ma, S.Y., Liu, H.M., Dou, Y.T., Fan, Y.C., Wang, S., Zhan, P., Gao, C.J., et al., 2024. Palmitoylation of TIM-3 promotes immune exhaustion and restrains antitumor immunity. Sci. Immunol. 9, eadp7302.
|
|
Zhong, Q., Xiao, X., Qiu, Y., Xu, Z., Chen, C., Chong, B., Zhao, X., Hai, S., Li, S., An, Z., et al., 2023. Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications. MedComm 4, e261.
|
|
Zhou, B., Zhang, B., Qi, Y., Li, S., Liu, T., Li, T., Wang, Y., Wang, H., Lu, J., Cao, F., et al., 2026. Palmitoylation-dependent regulation of innate and adaptive immunity: molecular insights and translational opportunities. Cell. Mol. Biol. Lett. 31, 77.
|
|
Zhou, B.H., Hao, Q.Y., Liang, Y.M., Kong, E.Y., 2022. Protein palmitoylation in cancer: molecular functions and therapeutic potential. Mol. Oncol. 17, 3-26.
|
|
Zhou, B.H., Wang, Y., Zhang, L.C., Shi, X.Y., Kong, H.S., Zhang, M.J., Liu, Y., Shao, X., Liu, Z.L., Song, H.X., et al., 2022. The palmitoylation of AEG-1 dynamically modulates the progression of hepatocellular carcinoma. Theranostics 12, 6898-6914.
|
|
Zhou, T.L., Li, J., Zhao, P.Q., Liu, H.J., Jia, D.Y., Jia, H., He, L., Cang, Y., Boast, S., Chen, Y.H., et al., 2015. Palmitoyl acyltransferase Aph2 in cardiac function and the development of cardiomyopathy. Proc. Natl. Acad. Sci. U. S. A. 112, 15666-15671.
|